Stocklytics Platform
Asset logo for symbol IRIX
IRIDEX
IRIX39
$1.00arrow_drop_up0.98%$0.00
Penny Stock
Asset logo for symbol IRIX
IRIX39

$1.00

arrow_drop_up0.98%

Performance History

Chart placeholder
Key Stats
Open$1.00
Prev. Close$0.99
EPS-0.67
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$16.78M
PE Ratio-
LOWHIGH
Day Range0.98
1.03
52 Week Range0.87
3.65
Ratios
Revenue-
EPS-0.67

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About IRIDEX (IRIX)

IRIDEX Corp is a medical device company that develops, manufactures, and markets ophthalmic laser systems for the treatment of glaucoma and retinal diseases. The company's flagship product, the Cyclo G6 Laser System, is used for the treatment of glaucoma and is considered the gold standard in cyclophotocoagulation. The system delivers controlled laser energy to the ciliary body to reduce intraocular pressure and preserve vision. In addition to glaucoma treatment, IRIDEX also offers laser systems for the treatment of retinal diseases, such as diabetic retinopathy and age-related macular degeneration. These systems provide high-precision laser delivery to the retina, enabling targeted treatment and improving patient outcomes.
IRIDEX Corp's stock price history shows a relatively stable performance over the past few years. The stock has experienced some fluctuations in response to market conditions and company news, but overall it has remained within a reasonable range. Investors should consider the company's strong market position, innovative product portfolio, and solid financial performance when evaluating the stock's potential for future growth. It is worth noting that IRIDEX Corp operates in a highly competitive industry, and its success is dependent on factors such as regulatory approvals, reimbursement rates, and market acceptance of its products.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. David I. Bruce
Headquarters
Mountain View
Employees
130
Exchange
NASDAQ
add IRIDEX to watchlist

Keep an eye on IRIDEX

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is IRIDEX's (IRIX) price per share?

The current price per share for IRIDEX (IRIX) is $1. The stock has seen a price change of $0.01 recently, indicating a 0.99% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for IRIDEX (IRIX)?

For IRIDEX (IRIX), the 52-week high is $3.65, which is 263.18% from the current price. The 52-week low is $0.88, the current price is 14.46% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is IRIDEX (IRIX) a growth stock?

IRIDEX (IRIX) has shown an average price growth of -1.65% over the past three years. It has received a score of 16 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying IRIDEX as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is IRIDEX (IRIX) stock price performance year to date (YTD)?

As of the latest data, IRIDEX (IRIX) has a year-to-date price change of -40.18%. Over the past month, the stock has experienced a price change of -7.8%. Over the last three months, the change has been -30.21%. Over the past six months, the figure is -44.17%. Looking at a longer horizon, the five-year price change stands at -42.95%.
help

Is IRIDEX (IRIX) a profitable company?

IRIDEX (IRIX) has a net income of -$9.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 42.04% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -16.15% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $21.81M. Operating income is noted at -$10.01M. Furthermore, the EBITDA is -$10.08M.
help

What is the market capitalization of IRIDEX (IRIX)?

IRIDEX (IRIX) has a market capitalization of $16.79M. The average daily trading volume is 0.99, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level